ReviewCureus2025
Hyperbilirubinemia as a Marker for Complicated Acute Appendicitis: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- CLR (CRP to Lymphocytes) Score for Differentiating Simple and Complicated Appendicitis in Pediatric Patients.Journal of clinical medicine · 2026Article
- Comparison of physical examination, laboratory and radiologic findings in the diagnosis of acute appendicitis.Northern clinics of Istanbul · 2026Article
- The Role of Emerging Immune-Inflammatory Indexes in the Preoperative Differentiation of Complicated and Uncomplicated Acute Appendicitis: A Single-Center Retrospective Analysis.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute appendicitis (AA) is one of the most common causes of acute abdomen requiring urgent surgical intervention, and early recognition of complicated forms, such as perforation or gangrene, is crucial to reducing mortality and complications. In recent years, bilirubin has gained attention as a potential biomarker of disease severity. The aim of this systematic literature review was to evaluate the diagnostic usefulness of total bilirubin concentration as a marker of complications in AA, with particular emphasis on perforation, and to analyze its effectiveness in differentiating uncomplicated and complicated forms. A systematic search of PubMed, ScienceDirect, and Google Scholar was performed to identify studies exploring the relationship between bilirubin levels and the severity of AA. The literature indicates a correlation between hyperbilirubinemia and perforated appendicitis. Bilirubin has higher diagnostic specificity compared to classical inflammatory markers such as leukocytosis or C-reactive protein (CRP), especially when combined with clinical assessment and imaging studies. Both retrospective and prospective studies suggest that elevated bilirubin significantly increases the risk of complicated disease. Based on the evidence synthesized in this review, hyperbilirubinemia appears to be associated with complicated forms of AA, particularly perforation. While it demonstrates higher specificity than classical inflammatory markers, the available studies emphasize that it should not be used as a stand-alone diagnostic marker. Instead, bilirubin may be considered a supportive parameter, particularly when interpreted together with clinical evaluation and imaging findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.